BCAL Diagnostics (ASX:BDX) Inventories, Raw Materials & Components: A$0.00 Mil (As of Dec. 2025)


What is BCAL Diagnostics Inventories, Raw Materials & Components?

BCAL Diagnostics ASX:BDX -3.70% Inventories, Raw Materials & Components is A$0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's inventories, raw materials & components for the quarter that ended in Dec. 2025 was A$0.00 Mil.

BCAL Diagnostics Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Inventories, Raw Materials & Components Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BCAL Diagnostics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of A$0.00 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Inventories, Raw Materials & Components of A$0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Inventories, Raw Materials & Components too high?
BCAL Diagnostics' current Inventories, Raw Materials & Components is A$0.00 Mil.
How does BCAL Diagnostics' Inventories, Raw Materials & Components compare to TMO and DHR?
BCAL Diagnostics' Inventories, Raw Materials & Components of A$0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Inventories, Raw Materials & Components is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Inventories, Raw Materials & Components of A$0.00 Mil. The current Inventories, Raw Materials & Components is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Inventories, Raw Materials & Components is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.